Cover Image

Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin

Saved in:

Bibliographic Details
Date:	2014
Main Authors:	V. F. Chekhun, Y. V. Lozovska, A. P. Burlaka, N. Y. Lukyanova, I. N. Todor, L. A. Naleskina
Format:	Article
Language:	English
Published:	2014
Series:	Experimental Oncology
Online Access:	http://jnas.nbuv.gov.ua/article/UJRN-0000294119
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Similar Items

Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin
by: Chekhun, V.F., et al.
Published: (2014)

Redox-regulation of gelatinases during growth of cisplatin-sensitive and resistant Guerin carcinoma
by: Burlaka, A.P., et al.
Published: (2015)

Redox-regulation of gelatinases during growth of cisplatin-sensitive and resistant Guerin carcinoma
by: A. P. Burlaka, et al.
Published: (2015)

Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
by: I. N. Todor, et al.
Published: (2015)

Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
by: Todor, I.N., et al.
Published: (2015)

Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
by: I. G. Tkalia, et al.
Published: (2014)

Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
by: Tkalia, I.G., et al.
Published: (2014)

Remodulating effect of doxorubicin on the state of iron-containing proteins, and redox characteristics of tumor with allowance for its sensitivity to cytostatic agents
by: V. F. Chekhun, et al.
Published: (2016)

The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)

Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin
by: Lukyanova, N.Yu., et al.
Published: (2009)

Relationship between malignant tumor metabolism and tumor-bearing organism
by: T. N. Popovskaja, et al.
Published: (2019)

In vitro modification of cisplatin cytotoxicity with magnetic fluid
by: Chekhun, V.F., et al.
Published: (2013)

Alteration in lipid composition of plasma membranes of sensitive and resistant Guerin carcinoma cells due to the action of free and liposomal form of cisplatin
by: Naleskina, L.A., et al.
Published: (2013)

Alteration in lipid composition of plasma membranes of sensitive and resistant Guerin carcinoma cells due to the action of free and liposomal form of cisplatin
by: L. A. Naleskina, et al.
Published: (2013)

Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
by: Potebnya, G.P., et al.
Published: (2009)

Biodistribution analysis of cisplatin in liposomal form in animals with cisplatinresistant and cisplatin-sensitive carcinoma
by: Nosko, M.M., et al.
Published: (2010)

Tumor microenvironment changes tumor cell sensitivity to action of energy metabolism modifiers
by: Pyaskovskaya, O.N., et al.
Published: (2023)

Influence of ferromagnetic nanocomposite (Ferroplat) on human breast cancer cells of different malignancy degrees: pro/antioxidant balance and energy metabolism
by: Chekhun, V.F., et al.
Published: (2018)

Expression of iron metabolism genes as markers of organ toxicity
by: I. P. Kindrat, et al.
Published: (2017)

Cisplatin treatment of C6 rat glioma in vivo did not influence copy number alterations and growth pattern of tumor-derived resistant cells
by: A. A. Stepanenko, et al.
Published: (2015)

Cisplatin treatment of C6 rat glioma in vivo did not influence copy number alterations and growth pattern of tumor-derived resistant cells
by: Stepanenko, A.A., et al.
Published: (2015)

Activity and content of antioxidant enzymes in prostate tumors
by: Kotrikadze, N., et al.
Published: (2008)

Mechanisms of morphology death of tumor cell by effect non-radioactive and radioactive ¹⁹⁵ᵐPt-cisplatin
by: Dikiy, N.P., et al.
Published: (2021)

Ultrastructural and some functional changes in tumor cells treated with stabilized iron oxide nanoparticles
by: Yurchenko, O.V., et al.
Published: (2010)

Estimation of the absorbed doses of synthesized cisplatin with ¹⁹⁵mPt in various organs of animals
by: Dikiy, N.P., et al.
Published: (2008)

Metalloproteins during development of Walker-256 carcinosarcoma resistant phenotype
by: V. F. Chekhun, et al.
Published: (2015)

Lipide metabolism in carp and pike organisms under effect of iron (III) ions
by: O. O. Rabcheniuk, et al.
Published: (2018)

Antineoplastic therapy by radioactive cisplatin in experiment
by: Dikiy, N.P., et al.
Published: (2007)

Impact of a tobacco smoke on a metabolism of an organ culture of bovine lenses and potential protection by antioxidants
by: E. A. Bormusova, et al.
Published: (2013)

Impact of a tobacco smoke on a metabolism of an organ culture of bovine lenses and potential protection by antioxidants
by: Bormusov, E., et al.
Published: (2013)

Activation of store – operated Ca2+ entry in cisplatin resistant leukemic cells after treatment with photoexcited fullerene C60 and cisplatin
by: D. V. Franskevych, et al.
Published: (2018)

Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018)

Protein and carbohydrate metabolism disorders in patients with malignant tumors of the intestine
by: T. N. Popovskaja, et al.
Published: (2018)

Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
by: Grybach, S.M., et al.
Published: (2018)

Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
by: Grybach, S.M., et al.
Published: (2018)

Tumor microenvironment and metabolic factors: contribution to gastric cancer
by: Bubnovskaya, L., et al.
Published: (2023)

Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
by: Chekhun, V.F., et al.
Published: (2009)

The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: S. V. Vtorushin, et al.
Published: (2014)

The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: Vtorushin, S.V., et al.
Published: (2014)

Peculiarities of phenylhydrazone of benzaldehyde antioxidant action
by: A. N. Nikolaevskij, et al.
Published: (2013)